To Evaluate the Safety and PK Characteristics in Healthy Volunteers-Livalozet

A Single Dose, Sequence-randomized, Open-label, 2x2 Crossover Study to Compare Pharmacokinetics Between Pitavastatn and Valsartan Co-administration and Livalo Complex Product in Healthy Male Subjects

The purpose of this study is to compare pharmacokinetics between Pitavastatin and Valsartan co-administration and Livalo fixed combination drug in healthy male subjects.

Inclusion Criteria:

• Healthy male volunteers
• Age 20-55 years at the time of Screening
• BMI 19-26 kg/m2 at the time of Screening

Exclusion Criteria:

• Received other investigational drug within 90 days prior to the first dose of study drug